Properties
Description
Mutated EGFR-IN-1 is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (L858R), EGFRExon 19 deletion/T790M, and EGFRT790M.
Molecular Formula
C25H31N7O
Targets
EGFR (L858R); EGFRExon 19 deletion/T790M; EGFRT790M
Identity
Confirmed by NMR/HPLC/MS.
Applications
EGFR-HER2 inhibitor Mutated EGFR-IN-1 is used to inhibit EGFR mutations that are implicated in various cancers, contributing to the development of targeted cancer therapies.
